SK280796B6 - Analóg substancie p - Google Patents

Analóg substancie p Download PDF

Info

Publication number
SK280796B6
SK280796B6 SK4028-90A SK402890A SK280796B6 SK 280796 B6 SK280796 B6 SK 280796B6 SK 402890 A SK402890 A SK 402890A SK 280796 B6 SK280796 B6 SK 280796B6
Authority
SK
Slovakia
Prior art keywords
phe
pro
leu
gln
trp
Prior art date
Application number
SK4028-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK402890A3 (en
Inventor
David H. Coy
Jacques-Pierre Moreau
Original Assignee
The Administrators Of The Tulane Educational Fund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Administrators Of The Tulane Educational Fund filed Critical The Administrators Of The Tulane Educational Fund
Publication of SK402890A3 publication Critical patent/SK402890A3/sk
Publication of SK280796B6 publication Critical patent/SK280796B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK4028-90A 1989-08-16 1990-08-16 Analóg substancie p SK280796B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39472789A 1989-08-16 1989-08-16

Publications (2)

Publication Number Publication Date
SK402890A3 SK402890A3 (en) 2000-07-11
SK280796B6 true SK280796B6 (sk) 2000-07-11

Family

ID=23560172

Family Applications (1)

Application Number Title Priority Date Filing Date
SK4028-90A SK280796B6 (sk) 1989-08-16 1990-08-16 Analóg substancie p

Country Status (15)

Country Link
EP (1) EP0438566B1 (de)
JP (1) JPH04502922A (de)
AT (1) ATE143372T1 (de)
CA (1) CA2039175A1 (de)
CZ (2) CZ285562B6 (de)
DD (1) DD298411A5 (de)
DE (1) DE69028692T2 (de)
DK (1) DK0438566T3 (de)
ES (1) ES2094160T3 (de)
GR (1) GR900100613A (de)
HU (1) HUT65465A (de)
IE (1) IE77033B1 (de)
PT (1) PT95016B (de)
SK (1) SK280796B6 (de)
WO (1) WO1991002745A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410019A (en) * 1987-09-24 1995-04-25 The Administrators Of The Tulane-Educational Fund Therapeutic peptides
FR2680174A1 (fr) * 1991-08-05 1993-02-12 Michelot Robert Nouveaux composes peptidiques, inhibiteurs de l'adsorption du virus hiv sur ses cellules cibles.
DK0533280T4 (da) 1991-09-20 2005-02-28 Glaxo Group Ltd Ny medicinsk anvendelse af tachykininantagonister
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
EP0835662B1 (de) * 1996-10-08 2001-11-14 National Institute of Immunology Arzneimittel zur Behandlung von Krebs
CA2225185A1 (en) 1997-08-11 1999-02-11 Peter K. Law Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
BRPI0807972A2 (pt) 2007-01-24 2014-06-10 Glaxo Group Ltd Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1
CN102612373B (zh) * 2009-11-11 2016-03-02 国立大学法人山口大学 消化器官疾病治疗剂
US9446029B2 (en) 2010-07-27 2016-09-20 Colorado State University Research Foundation Use of NK-1 receptor antagonists in management of visceral pain
WO2023139542A1 (en) * 2022-01-21 2023-07-27 Institut Pasteur De Montevideo Active immunization for reducing osteoarthritic, neuropathic, and cancer pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862114A (en) * 1971-11-22 1975-01-21 Ici Australia Ltd Analogs of substance p
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
US4481139A (en) * 1983-04-13 1984-11-06 Board Of Regents, The University Of Texas System Peptide antagonists of substance P
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
NZ229552A (en) * 1988-06-20 1992-06-25 Merrell Dow Pharma Neurokinin a antagonists

Also Published As

Publication number Publication date
DE69028692T2 (de) 1997-02-20
SK402890A3 (en) 2000-07-11
ES2094160T3 (es) 1997-01-16
PT95016A (pt) 1991-04-18
CZ285319B6 (cs) 1999-07-14
CZ285562B6 (cs) 1999-09-15
WO1991002745A1 (en) 1991-03-07
CA2039175A1 (en) 1991-02-17
EP0438566A4 (en) 1993-03-31
DK0438566T3 (da) 1996-11-11
GR900100613A (el) 1991-12-30
CZ402890A3 (cs) 1999-04-14
EP0438566A1 (de) 1991-07-31
IE77033B1 (en) 1997-11-19
ATE143372T1 (de) 1996-10-15
HU906872D0 (en) 1991-07-29
EP0438566B1 (de) 1996-09-25
PT95016B (pt) 1997-05-28
DD298411A5 (de) 1992-02-20
HUT65465A (en) 1994-06-28
JPH04502922A (ja) 1992-05-28
IE902958A1 (en) 1991-02-27
DE69028692D1 (de) 1996-10-31

Similar Documents

Publication Publication Date Title
US5410019A (en) Therapeutic peptides
EP0489089B1 (de) Heilmittelpeptide
US5877277A (en) Octapeptide bombesin analogs
US5552520A (en) Therapeutic peptide derivatives
JP2919889B2 (ja) 治療用ペプチド
US5175146A (en) Synthetic calcitonin peptides
WO1989002897A1 (en) Therapeutic peptides
US5106834A (en) Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
US5723578A (en) Peptide analogs of bombesin
SK280796B6 (sk) Analóg substancie p
US4724229A (en) Arg-arg-arg-vasopressin antagonists
US4826813A (en) 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists
RU2088592C1 (ru) Терапевтические пептиды или их фармацевтически приемлемые соли
AU622123C (en) Therapeutic peptides
HU211513A9 (hu) Az átmeneti oltalom az 1-9. igénypontokra vonatkozik
Cascieri et al. Characterization of Tachykinin Receptors by Ligand Binding Studies and by Utilization of Conformationally Restricted Tachykinin Analogues